NYSE Regulation initiated delisting proceedings against Know Labs, Inc., citing the company's unsuitability for listing under Section 1003(f)(v) of the NYSE American Company Guide. This determination was made because the company's bid price fell below $0.10.
Effective January 29, 2025, the company's stock was suspended from trading on the NYSE American. FINRA’s Department of Market Operations subsequently assigned the symbol "KNWN" for the quotation and trading of Know Labs' stock in the over-the-counter (OTC) market.
Know Labs stated it is working on curative actions to regain compliance and plans to appeal the NYSE's determination to the Listings Qualifications Panel of the Exchange. The CEO, Ron Erickson, expressed commitment to advancing the company's business plan despite the delisting.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.